Need help?

Diagnostic Labs for Sale and Investment in USA

Showing 1 - 6 of 6 Diagnostic Labs for Sale and Investment in USA. Buy or Invest in a Diagnostic Lab, Pathology Business, Radiology Center or a Laboratory. Listed by Direct Business Owners & Business Brokers.
Filters
  • Diagnostic Labs

  • USA

 

Newly Established Diagnostic Lab Equity Stake For Sale in Tampa, USA

Pre-revenue cancer diagnostics startup seeks investment to launch a pan-cancer therapy guidance test.
The startup is in the pre-revenue, pre-launch stage. - The business is incorporated as a C-Corporation in the State of Delaware, but the acquired laboratory facility is located in Tampa, Florida, where the operations will be based. - One of the two co-founders is currently based in New York, NY, and the other in Chicago, IL. - The co-founders have developed and validated a highly innovative platform technology that enables delivery of a cancer diagnostic test providing therapy guidance across multiple cancer types and treatment modalities, including surgery, radiation, chemotherapy, immunotherapy, and targeted therapy. - The total addressable market (TAM) in the U. S. is approximately $3.6B, with a serviceable available market (SAM) of $2.3B and a serviceable obtainable market (SOM) of $90–116M at full platform scale. - For the U. S. market, the company plans to drive sales and marketing efforts targeting both patients and their physicians. - For international markets, particularly the EU, Latin America, Gulf/MENA, and Southeast Asia, the company intends to engage distribution partners. - In less developed markets, distribution will be managed directly through professional networks and online sales programs targeting patients and physicians. - The co-founder brings extensive experience in life sciences and diagnostics investment banking, having led multiple mergers, acquisitions, and corporate transactions in the diagnostics sector. He is also the architect of the multi-stack AI reporting system that provides a key competitive advantage. - The technical co-founder has over 15 years of experience in NIH-funded cancer research (SBIR Phase I & II awardee) and has developed the core test paradigm and proprietary predictive algorithms that form the foundation of the platform.
6.4   Tampa
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 3 Mn for 15%
Contact Business

Newly Established Diagnostic Lab for Sale in New York City, USA

Brooklyn-based outpatient clinic with infrastructure and patient base, seeking buyer for expansion or ownership transition.
Operates an established outpatient healthcare clinic offering primary care, urgent care, preventive services, and basic diagnostic support. - Serves local individuals, families, workers, and students requiring convenient access to same-day visits, routine checkups, screenings, and medical documentation. - Fully operational facility with existing patient flow, enabling immediate continuation without setup delays. - Clinic includes professionally arranged medical office space with dedicated clinical and administrative areas. - Equipped with necessary furniture, fixtures, and medical equipment to support day-to-day operations. - Designed for a smooth ownership transition with existing infrastructure, systems, and workflows already in place. - Eliminates the need for new build out, licensing setup, and early-stage patient acquisition. - Positioned for expansion across primary care, urgent care, wellness, and preventive healthcare services. - Growth potential through extended hours, additional provider coverage, service expansion, and improved marketing efforts. - The clinic operates with valid medical license. - Suitable for individual practitioners, medical groups, or healthcare entrepreneurs seeking entry or expansion in a dense urban market.
Brooklyn-based outpatient clinic with infrastructure and patient base, seeking buyer for expansion or ownership transition.
6.2   New York City
Run Rate Sales
USD 306 thousand
EBITDA Margin
10 %
Business for Sale
USD 350 K
Contact Business

Diagnostic Lab Seeking Loan in Dallas, USA

Multi-specialty medical practice using AI diagnostics to optimize personal injury treatment, seeks funding for expansion.
A licensed multi-specialty personal-injury medical practice operating across four major Texas metros with full Texas state credentials. - Established partnerships with PI funding leaders (One Health Solutions, Cutting Edge, Certified Injury, PFD) to streamline claim funding without lengthy credentialing delays. - Leadership team includes the founder of the institute for coaching medical professionals and a kinesiology & chiropractic expert, together bringing 30+ years of PI clinical and operational experience. - Serves over 5,300 personal-injury patients annually, generating $23.9 M in service revenue in the last year with net revenue of $4.8 M; YTD net patient revenue stands at $1.18 M. - Revenue model bills PI claims at contractual allowances (80% discounts, stepping down to 60% post-funding) leveraged by AI-driven fee optimization. - Employs 60+ clinicians delivering 15+ service lines - TBI testing, brain mapping, EMG/NCV, interventional pain, rehab therapies, backed by AI-powered diagnostics for rapid and precise reporting. - Strategic clinical alliances with Advance Imaging Center and Strategic Medical Management plus a robust referral network of PI attorneys accelerate interdisciplinary care. - Expansion underway into California, Florida, Georgia, and Missouri, with telemedicine and specialized wound-care programs identified as high-growth opportunities. - Our practitioners are licensed and we do not require any special regulatory license to operate a medical practice.
6.9   Dallas
Run Rate Sales
USD 24 million
EBITDA Margin
Operating at loss
Business Loan
USD 5 Mn at 20%
Contact Business
List your business on SMERGERS.
Get visibility from 110,000+ member network of Businesses, Investors, Acquirers, Lenders and Advisors from 900+ Industries and 170+ Countries
Create Business Profile

Diagnostic Lab Seeking Loan in Dallas, USA

Multi-specialty medical practice using AI diagnostics to optimize personal injury treatment, seeks funding for expansion.
A licensed multi-specialty personal-injury medical practice operating across four major Texas metros with full Texas state credentials. - Established partnerships with PI funding leaders (One Health Solutions, Cutting Edge, Certified Injury, PFD) to streamline claim funding without lengthy credentialing delays. - Leadership team includes the founder of the institute for coaching medical professionals and a kinesiology & chiropractic expert, together bringing 30+ years of PI clinical and operational experience. - Serves over 5,300 personal-injury patients annually, generating $23.9 M in service revenue in the last year with net revenue of $4.8 M; YTD net patient revenue stands at $1.18 M. - Revenue model bills PI claims at contractual allowances (80% discounts, stepping down to 60% post-funding) leveraged by AI-driven fee optimization. - Employs 60+ clinicians delivering 15+ service lines - TBI testing, brain mapping, EMG/NCV, interventional pain, rehab therapies, backed by AI-powered diagnostics for rapid and precise reporting. - Strategic clinical alliances with Advance Imaging Center and Strategic Medical Management plus a robust referral network of PI attorneys accelerate interdisciplinary care. - Expansion underway into California, Florida, Georgia, and Missouri, with telemedicine and specialized wound-care programs identified as high-growth opportunities. - Our practitioners are licensed and we do not require any special regulatory license to operate a medical practice.
6.9   Dallas
Run Rate Sales
USD 24 million
EBITDA Margin
Operating at loss
Business Loan
USD 5 Mn at 20%
Contact Business

Profitable Diagnostic Lab Equity Stake For Sale in Wilmington, USA

AI-driven diagnostics innovator, leveraging strategic alliances, is now seeking stakeholders for further growth.
Business Highlights: - Founded 4 years ago, began with a COVID-19 experiment using 1,300 samples, achieving an impressive 99.77% accuracy compared to RT-PCR. - Intellectual property: Secured a patent grant, solidifying our innovative approach in AI-driven diagnostics. - Accelerator & industry recognition: Selected for The Roux Institute’s Future of Healthcare acceleration program, providing mentorship and strategic growth opportunities. - Non-dilutive & early investment traction: Gained momentum with multiple grants and secured a $50K pre-seed investment, fueling research and development. - E. coli study success: Conducted a preclinical study demonstrating 87% accuracy, further validating our RF-based pathogen detection technology. - Funding & resources: Currently leveraging USD 725K in total grants and credits, including K in USD 70 K grants received, USD 350K in Google Cloud credits, and an expected USD 305K SBIR grant from NSF. - Industry partnerships & market strategy: -- NorDx is set to be our first commercial client upon market entry. - Recognition & awards: -- Accepted into the Nvidia Inception Program for AI innovation. -- Runner-up in the AWS x Nvidia pitch competition in Austin, positioning business at the forefront of AI-powered diagnostics. - Market Launch & Revenue. - Fundraising progress: Raising USD 3M to commercialize, with USD 105K secured through SAFE notes and strong investor interest. - Business Model & Revenue Potential: Projected first-year revenue of USD 3M, with sales of 600 diagnostic units upon launch. Scalable B2B model targeting diagnostic labs, hospitals, and healthcare providers. - Potential for recurring revenue streams through AI-powered diagnostic subscriptions and consumables. - Regulatory & Clinical Traction for a Competitive Edge. Ongoing clinical validation and regulatory alignment with CLIA/CAP-accredited labs. RF-based diagnostics provide a faster, non-invasive alternative to traditional molecular testing. - With high asset valuation, driven by significant equipment costs, the company stands out in the diagnostics sector with its advanced technological infrastructure. - With a compact team of 6 skilled employees, the business emphasizes agility and innovation in its operations, facilitating quick progress in the fast-paced diagnostic technology sector.
AI-driven diagnostics innovator, leveraging strategic alliances, is now seeking stakeholders for further growth.
8.1   Wilmington
Run Rate Sales
USD 26.4 thousand
EBITDA Margin
30 %
Partial Stake Sale
USD 500 K for 20%
Contact Business

Profitable Diagnostic Lab Equity Stake For Sale in Weaverville, USA

Mobile phlebotomy services in North Carolina performing 4-7 daily blood draws, seeking investment.
Business specializing in mobile phlebotomy services and lab tests, located in North Carolina. - Provides mobile blood draws, serving individuals at their doorstep. - Partnered with 4 labs and 2 doctors, enhancing service offerings and expanding client base. - Current service capacity allows for 4-7 blood draws per day. - Charges a competitive flat rate plus $60/mile for travel, providing transparent pricing to clients. - Licensed phlebotomy professional, ensuring compliance with healthcare regulations and high-quality service delivery. - Experiencing challenges with timely payments from select partners. - Strong potential for growth in the mobile healthcare sector, tapping into the increasing demand for at-home and accessible healthcare services.
6.5   Weaverville
Run Rate Sales
USD 36 thousand
EBITDA Margin
25 %
Partial Stake Sale
USD 50 K for 45%
Contact Business

Clinic Franchise Opportunity

Intel-Scan, 5 Franchisees, Est'd in 2013, Chandigarh HQ
  • 10000+ Page Views
  • 4000+ Investor Views
The brand Intel-Scan is a home-based diagnosis tool in the form of a mobile application that is integrated with artificial intelligence using voice analysis to detect missing body frequencies. Categories: • Preventive health. • Home based health services. • Digital health. Record voice: AI gives you in seconds: • Full body reporting. • Immunity status. • 7 chakra status. • 5 element status. • Covid risk calculation. • Organ risk calculation. • Multiple treatment options: as per the stage of the disease and recommends list of pharmacies, path labs, doctors and hospitals near by and options for online consultation. Business model is mainly B2C. A parallel health care system platform that is both: 1. Preventive in nature with early and accurate Diagnosis-secondary prevention as per. WHO guidelines: 1984 Geneva Convention. 2. Curative: with online doctors, path labs, pharmacies, and hospitals. 3. Home based: all services delivered at Home. No hospital visits required. A common platform for: • Diagnosis tools Home Based. • End users. • Path labs. • Pharmacies. • Doctors. • Hospitals. Advantages- Home based health care services inclusive of: • Diagnosis at home using mobile phone app-Intel-Scan. • Lab tests. • Procuring medicines. • Consulting doctors online. • Visiting hospitals with online appointment. • Ambulance services. Unique selling proposition. • World’s first Ever tool that fulfills WHO guidelines for secondary prevention (early diagnosis) • Unique technology in early diagnosis and screening. • Patented technology in preventive health care for early diagnosis and screening. • No competitor's. • Only full body scan with reporting in 30 sec@ home using AI and voice analysis. • Beneficial in pandemic situations as a non contact diagnosis tool for viral and other infections. • Covid diagnosis sitting at home. • Covid mass screening – up to 5 crore people in one day. • Safer -no radiation hazard. • Scalable. • Potential of mass adoption.
Intel-Scan, 5 Franchisees, Est'd in 2013, Chandigarh HQ
8.6   Expanding in USA
Exp Monthly Sales
USD 1.05 thousand
Space Required
150 - 300 Sq Ft
Investment Required
USD 3.2 - 5.3 K
Contact Company

Browse Businesses by Location

Frequently
Asked
Questions
  • How many diagnostic labs for sale and investment in USA are listed on SMERGERS?
    There are 6 active and verified diagnostic labs for sale and investment in USA listed on SMERGERS as of 02 November 2026.
  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more

Chat with Us
Welcome to SMERGERS